Literature DB >> 7421276

Metastatic basal cell carcinoma.

E F Scanlon, D D Volkmer, M A Oviedo, J D Khandekar, T A Victor.   

Abstract

The primary mode of spread of basal cell carcinoma is by direct extension. From 1894 to June 1977, 119 cases of metastatic basal cell carcinoma were reported in the world literature. We wish to report five additional cases. It is our feeling that the spread of these tumors is by the interstitial route. It is standard teaching that the interstitial embolic spread of cancer does not occur, but these five cases give strong supporting evidence to the previously reported suggestion that this route of spread may be common. The concept has considerable implications regarding treatment of most cancers.

Entities:  

Mesh:

Year:  1980        PMID: 7421276     DOI: 10.1002/jso.2930150208

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  6 in total

Review 1.  Cell-contact and -architecture of malignant cells and their relationship to metastasis.

Authors:  A Raz; A Ben-Ze'ev
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

Review 2.  Basal cell carcinoma.

Authors:  J T Lear; A G Smith
Journal:  Postgrad Med J       Date:  1997-09       Impact factor: 2.401

3.  Neglected Basal Cell Carcinoma on Scalp.

Authors:  Sudip Sarkar; Pranaya Kunal; Barunesh Kishore; Kisalay Ghosh
Journal:  Indian J Dermatol       Date:  2016 Jan-Feb       Impact factor: 1.494

4.  The demonstration of nonlinear development of experimental lung tumor metastases.

Authors:  A Raz
Journal:  Clin Exp Metastasis       Date:  1984 Jan-Mar       Impact factor: 5.150

5.  Simultaneous two organ metastases of the giant basal cell carcinoma of the skin.

Authors:  Eray Copcu; Alper Aktas
Journal:  Int Semin Surg Oncol       Date:  2005-01-04

6.  Profile of vismodegib and its potential in the treatment of advanced basal cell carcinoma.

Authors:  Muzafar A Macha; Surinder K Batra; Apar Kishor Ganti
Journal:  Cancer Manag Res       Date:  2013-07-31       Impact factor: 3.989

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.